David Simmonds

Bereavement Support Payment (BSP) helps people through the immediate period following a bereavement by way of an initial lump sum followed by up to 18 monthly instalments. Where longer-term financial support is needed, benefits such as Universal Credit have been specifically designed to provide assistance with ongoing living costs. We have no current plans to change the duration of Bereavement Support Payment.

The rate of Bereavement Support Payment is reviewed on a discretionary basis as part of the annual uprating process, but there is no legal requirement to uprate it. BSP is not a cost-of-living benefit like Universal Credit, which has been increased in line with inflation. We will review the rate of Bereavement Support Payment later this year as part of the annual uprating process.

The Department awards funding to encourage participation of brain tumour patients in clinical trials through the National Institute of Health and Care Research (NIHR), the Department’s research delivery arm. Funding is awarded through open competition, and researchers are expected to include a robust plan for patient and public involvement as part of their application.

Between 2018/19 and 2022/2, the NIHR has invested £11.3 million directly in brain tumour research, as well as investing £31.5 million in research infrastructure, including facilities, services, and the research workforce, allowing research funding to be leveraged from other donors and organisations. This funding has allowed 227 brain cancer research studies to be carried out and enabled 8,500 people to participate in potentially life-changing research into brain cancer within the National Health Service.

In addition, the NIHR provides an online service called Be Part of Research which promotes participation in health and social care research by allowing users to search for relevant studies and register their interest. This makes it easier for people to find and take part in health and care research that is relevant to them, such as brain cancer.

In September 2024, the NIHR announced a new approach to transform the outcomes for patients who are living with brain tumours and their families, ultimately reducing the lives lost to cancer, with a new national Brain Tumour Research Consortium, a new research funding call, and a new Tessa Jowell Allied Health Professional research fellowship.

The Department is committed to working with the pharmaceutical industry to implement the recommendations of Lord O'Shaughnessy’s review into commercial clinical trials, maximising our potential to be a world leader in clinical trials.

The current programme governance groups overseeing the delivery on the recommendations of Lord O'Shaughnessy’s review, including improving access to clinical trials across the United Kingdom, includes representatives from the pharmaceutical industry and across the clinical research sector.

Through this programme, the Department is committed to working with the pharmaceutical industry to develop a more efficient, more competitive, and more accessible clinical research system in the UK, ensuring that all patients, including those with brain tumours, have access to cutting-edge clinical research and innovative, lifesaving treatments.

The Department is committed to ensuring that innovative, lifesaving treatments are accessible to National Health Service patients, including those with brain tumours, and to implementing the recommendations of Lord O'Shaughnessy’s review into commercial clinical trials, making sure that the United Kingdom leads the world in clinical trials.

The Department funds research and research infrastructure, which supports brain tumour patients and the public to participate in high-quality research, through the National Institute of Health and Care Research (NIHR).

In September 2024, the NIHR announced a new approach to transform the outcomes for patients and their families who are living with brain tumours, ultimately reducing the lives lost to cancer, with a new national Brain Tumour Research Consortium, a new research funding call, and a new Tessa Jowell Allied Health Professional research fellowship.

The Department is committed to ensuring that innovative, lifesaving treatments are accessible to National Health Service patients, including those with brain tumours, and to implementing the recommendations of Lord O'Shaughnessy’s review into commercial clinical trials, making sure that the United Kingdom leads the world in clinical trials.

The Department funds research and research infrastructure, which supports brain tumour patients and the public to participate in high-quality research, through the National Institute of Health and Care Research (NIHR).

In September 2024, the NIHR announced a new approach to transform the outcomes for patients and their families who are living with brain tumours, ultimately reducing the lives lost to cancer, with a new national Brain Tumour Research Consortium, a new research funding call, and a new Tessa Jowell Allied Health Professional research fellowship.

Research is crucial in tackling cancer, which is why the Department spends £1.5 billion each year on research through its research delivery arm, the National Institute for Health and Care Research (NIHR). Cancer is the largest area of spend, at over £121.8 million in 2022/23, and with the NIHR spending more on cancer than any other disease group, reflecting its high priority.

Over the last five years, the NIHR has directly invested £11.3 million on brain tumour research. In addition, our wider investments in NIHR research infrastructure, facilities, services, and the research workforce, allows us to leverage research funding from other donors and organisations. These investments are estimated to be £31.5 million, between 2018/19 and 2022/23, and have enabled 227 brain cancer research studies to take place in the same period. In total, NIHR investments have enabled 8,500 people to participate in potentially life-changing research in the National Health Service over this time. These investments are complemented by efforts led by UK Research and Innovation and the Medical Research Council.

Brain cancer remains one of the hardest to treat cancers in both adults and children and we urgently need more research to inform our efforts, which is why the NIHR announced new research funding opportunities for brain cancer research last month, spanning both adult and paediatric populations. This includes a national NIHR Brain Tumour Research Consortium, to ensure the most promising research opportunities are made available to adult and child patients, and a new funding call to generate high quality evidence in brain tumour care, support, and rehabilitation. Further information is available at the following link:

https://www.nihr.ac.uk/news/new-funding-opportunities-novel-brain-tumour-research-launched

Brain cancer and children's cancer research will continue to be a priority into the future, and the Department, through the NIHR, will continue to fund high-quality science to expand lifesaving and life-improving research.

The Foreign, Commonwealth and Development Office (FCDO) has not received representations from Great Britain-China Centre regarding the Chinese Embassy's planning application. It is not for the FCDO to receive "representations" on this matter. Any representations should have been provided to Tower Hamlets Council or, post call-in, to the planning inspectorate.

This government has prioritised working to end this conflict and secure the safe release of hostages still cruelly detained by Hamas since day one.  During their joint visit to the region, the Foreign Secretary and French Foreign Secretary Stéphane Séjourné met with Israel's Foreign Minister Israel Katz to reiterate the need to end the conflict in Gaza and secure the release of hostages. Both the Foreign Secretary and I have met with hostage families with links to the UK whose loved ones have been murdered or taken by Hamas and reiterated our commitment to using all diplomatic avenues to secure their release.

We welcome the tireless efforts of our partners in Qatar, Egypt and the United States, and fully endorse their joint statement calling for the immediate resumption of ceasefire negotiations and a hostage release deal between Israel and Hamas.  This deal is the best way to get the remaining hostages out. We are urging all sides to show flexibility.

The Foreign Secretary noted in his statement to the House of Commons on 19 July 2024, that the UN had taken the allegations that United Nations Relief and Works Agency for Palestine Refugees in the Near East (UNRWA) staff were involved in the 7 October Hamas terrorist attack seriously. He is reassured after Catherine Colonna's independent review, that UNRWA is ensuring the highest standards of neutrality.

£1 million of the £21 million of new UK funding to UNRWA will support it to implement the management reforms recommended by the review. We continue to monitor UNRWA's implementation. Separately, a Memorandum of Understanding governs UK financial support to UNRWA. The FCDO carries out due diligence assessments and conducts an annual assessment of UK funding to UNRWA.

The treatment of hostages still cruelly detained by Hamas is a matter of international concern. We are clear in our call - Hamas must release all hostages immediately. This government has prioritised working to end this conflict and secure the safe release of hostages since day one. The Foreign Secretary and I have both recently met with families with links to the UK whose loved ones have been murdered or taken by Hamas and reiterated our commitment to using all diplomatic avenues to secure their release.

We welcome the tireless efforts of our partners in Qatar, Egypt and the United States, and fully endorse their joint statement calling for the immediate resumption of ceasefire negotiations and a hostage release deal between Israel and Hamas. This deal is the best way to get the remaining hostages out. We are urging all sides to show flexibility.

The Foreign Secretary noted in his statement to the House of Commons on 19 July 2024, that the UN had taken the allegations that United Nations Relief and Works Agency for Palestine Refugees in the Near East (UNRWA) staff were involved in the 7 October Hamas terrorist attack seriously. He is reassured after Catherine Colonna's independent review, that UNRWA is ensuring the highest standards of neutrality.

£1 million of the £21 million of new UK funding to UNRWA will support it to implement the management reforms recommended by the review. We continue to monitor UNRWA's implementation. Separately, a Memorandum of Understanding governs UK financial support to UNRWA. The FCDO carries out due diligence assessments and conducts an annual assessment of UK funding to UNRWA.

The subsidised housing indicator is the only value significant code used in the Automated Valuation Model, as detailed in the response to UIN 16941.

The Royal Mint site near the Tower of London was sold by the Crown Estate in 2010 and, as such, there is no residual financial interest to the Exchequer from The Crown Estate.

HM Treasury has not made specific representations to the Ministry for Housing, Communities and Local Government on the proposed Chinese Embassy at the Royal Mint site in London. Information relating to HMT agencies is not held centrally and could only be provided at disproportionate cost.

The approach has been endorsed in reviews by both the Centre for Appraisal Research and Technology and the International Association of Assessing Officers.

Autumn Budget 2024 announced the extension of Retail, Hospitality and Leisure (RHL) relief for one year at 40 per cent up to a cash cap of £110,000 per business, and the freezing of the small business multiplier for 2025-26. This is a package worth over £1.6 billion in 2025-26.

For both business rates measures, the breakdown of costings over the scorecard period can be found on page 120 (lines 47-48) in ‘Chapter 5: Policy decisions’ of Autumn Budget 2024: https://assets.publishing.service.gov.uk/media/672b9695fbd69e1861921c63/Autumn_Budget_2024_Accessible.pdf

As set out in the Government’s impact note, using Department for Education data the Government has identified 2,444 private schools in England, of which 1,139 are charities.

Private schools that are wholly concerned with the training or welfare of disabled people will be exempt from business rates under existing provision. Private schools that are wholly or mainly concerned with providing education for pupils with an EHCP will also retain their charitable rate relief. Taken together, the Government expects the number of private schools that will lose business rates charitable relief to be 1,040.

Government analysis also shows the average increase in business rates per pupil to be £308 in the financial year 2025-26. This note can be found here: https://publications.parliament.uk/pa/bills/cbill/59-01/0129/ImpactNote.pdf